Virtual Tumor Board: GI

Virtual Tumor Board: GI - April 2021

Activity Overview

In this tumor board, the participants will be able to:

Identify Peptide Recteptor Radionuclide Therapy (PRRT) as a treatment modality in neuroendocrine tumors
Identify necessary tumor characteristics and radiographic workup prior to use of PRRT
Recognize considerations for initiation of PRRT in the spectrum of other treatment modalities for neuroendocrine tumors
Learn side effect profile of PRRT

Moderating this session will be Thomas Clancy, MD, FACS, Brigham and Women’s Hospital/Dana-Farber Cancer Institute.

Panelists:
Julie Hallet, MD, MSc, FRCSC, Susan Leslie Neuroendocrine Tumors Clinic, Sunnybrook Health Sciences Centre
Alexandra Gangi, MD, Cedars Sinai Medical Center
Pamela Kunz, MD, Yale School of Medicine
Thomas Hope, MD, University of California, San Francisco

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered